US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist

1.0400
+0.0100+0.97%

Close May 17 16:00 ET

1.0100
-0.0300-2.88%

Post 19:49 ET

39.11MMarket Cap-1130P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-64.69%-6.46M

-16.82%-18.28M

27.04%-4.44M

-24.11%-4.42M

-80.57%-5.5M

-32.57%-3.92M

-171.39%-15.65M

-333.64%-6.08M

-2.56%-3.56M

-1,304.15%-3.05M

Net income from continuing operations

-43.83%-20.96M

-69.14%-30.54M

-46.36%-7.8M

22.03%-4.33M

-5.56%-3.84M

-312.07%-14.58M

-80.27%-18.06M

-93.60%-5.33M

-6.84%-5.56M

-230.55%-3.64M

Operating gains losses

13.81%11.81M

--10.3M

--1.61M

---1.4M

---282K

--10.38M

----

Depreciation and amortization

531.11%284K

76.40%284K

95.24%82K

97.50%79K

95.00%78K

15.38%45K

1,138.46%161K

223.08%42K

--40K

Other non cash items

----

-99.35%21K

----

Change In working capital

1,980.22%1.89M

-107.89%-93K

210.33%1.12M

-82.29%299K

-729.02%-1.6M

-63.75%91K

1,221.90%1.18M

-184.11%-1.02M

231.98%1.69M

72.30%255K

-Change in prepaid assets

297.63%1.34M

-1,901.61%-1.12M

328.96%767K

-388.16%-1.11M

-406.35%-1.11M

28.52%338K

104.68%62K

-175.79%-335K

86.76%-228K

704.44%362K

-Change in payables and accrued expense

525.91%822K

0.71%1.28M

166.61%427K

-24.05%1.48M

-531.43%-442K

-904.17%-193K

2.84%1.27M

-182.39%-641K

341.08%1.95M

-167.96%-70K

-Change in other current liabilities

-405.56%-273K

-66.89%-252K

-82.50%-73K

-89.47%-72K

-43.24%-53K

-50.00%-54K

-1,158.33%-151K

-233.33%-40K

---38K

---37K

Cash from discontinued investing activities

Operating cash flow

-64.69%-6.46M

-16.82%-18.28M

27.04%-4.44M

-24.11%-4.42M

-80.57%-5.5M

-32.57%-3.92M

-171.39%-15.65M

-333.64%-6.08M

-2.56%-3.56M

-1,304.15%-3.05M

Investing cash flow

Cash flow from continuing investing activities

-6K

-500.00%-12K

-12K

93.10%-2K

Net PPE purchase and sale

---6K

-500.00%-12K

--0

---12K

--0

93.10%-2K

--0

Cash from discontinued investing activities

Investing cash flow

---6K

-500.00%-12K

--0

---12K

--0

93.10%-2K

--0

Financing cash flow

Cash flow from continuing financing activities

64.37%45.69M

5,947.35%27.54M

56.48%-205K

-51K

27.8M

-102.11%-471K

-471K

Net common stock issuance

----

--0

----

-99.95%11K

----

Net preferred stock issuance

65.62%50M

--30.19M

--0

--30.19M

--0

Net other financing activities

-80.07%-4.31M

-449.59%-2.65M

---205K

---51K

--0

---2.39M

---482K

----

Cash from discontinued financing activities

Financing cash flow

64.37%45.69M

5,947.35%27.54M

56.48%-205K

---51K

--0

--27.8M

-102.11%-471K

---471K

--0

Net cash flow

Beginning cash position

2,032.09%9.7M

-97.26%455K

104.64%14.35M

77.98%18.82M

78.65%24.33M

-97.26%455K

--16.58M

-61.08%7.01M

1,057,200.00%10.57M

9,165.31%13.62M

Current changes in cash

64.30%39.23M

157.34%9.25M

29.15%-4.64M

-25.54%-4.47M

-80.96%-5.51M

906.93%23.88M

-197.26%-16.12M

-357.75%-6.56M

-119.78%-3.56M

-1,986.99%-3.05M

End cash Position

101.09%48.93M

2,032.09%9.7M

104.64%14.35M

77.98%18.82M

78.65%24.33M

-97.26%455K

-61.08%7.01M

1,057,200.00%10.57M

Free cash flow

-64.85%-6.46M

-16.88%-18.3M

27.04%-4.44M

-24.11%-4.42M

-80.96%-5.51M

-32.48%-3.92M

-170.07%-15.65M

-324.86%-6.08M

-2.56%-3.56M

-1,304.15%-3.05M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-64.69%-6.46M	-16.82%-18.28M	27.04%-4.44M	-24.11%-4.42M	-80.57%-5.5M	-32.57%-3.92M	-171.39%-15.65M	-333.64%-6.08M	-2.56%-3.56M	-1,304.15%-3.05M
Net income from continuing operations	-43.83%-20.96M	-69.14%-30.54M	-46.36%-7.8M	22.03%-4.33M	-5.56%-3.84M	-312.07%-14.58M	-80.27%-18.06M	-93.60%-5.33M	-6.84%-5.56M	-230.55%-3.64M
Operating gains losses	13.81%11.81M	--10.3M	--1.61M	---1.4M	---282K	--10.38M	----	----	----	----
Depreciation and amortization	531.11%284K	76.40%284K	95.24%82K	97.50%79K	95.00%78K	15.38%45K	1,138.46%161K	223.08%42K	--40K	--40K
Other non cash items	----	----	----	----	----	----	-99.35%21K	----	----	----
Change In working capital	1,980.22%1.89M	-107.89%-93K	210.33%1.12M	-82.29%299K	-729.02%-1.6M	-63.75%91K	1,221.90%1.18M	-184.11%-1.02M	231.98%1.69M	72.30%255K
-Change in prepaid assets	297.63%1.34M	-1,901.61%-1.12M	328.96%767K	-388.16%-1.11M	-406.35%-1.11M	28.52%338K	104.68%62K	-175.79%-335K	86.76%-228K	704.44%362K
-Change in payables and accrued expense	525.91%822K	0.71%1.28M	166.61%427K	-24.05%1.48M	-531.43%-442K	-904.17%-193K	2.84%1.27M	-182.39%-641K	341.08%1.95M	-167.96%-70K
-Change in other current liabilities	-405.56%-273K	-66.89%-252K	-82.50%-73K	-89.47%-72K	-43.24%-53K	-50.00%-54K	-1,158.33%-151K	-233.33%-40K	---38K	---37K
Cash from discontinued investing activities
Operating cash flow	-64.69%-6.46M	-16.82%-18.28M	27.04%-4.44M	-24.11%-4.42M	-80.57%-5.5M	-32.57%-3.92M	-171.39%-15.65M	-333.64%-6.08M	-2.56%-3.56M	-1,304.15%-3.05M
Investing cash flow
Cash flow from continuing investing activities	-6K	-500.00%-12K	0	0	-12K	0	93.10%-2K	0	0	0
Net PPE purchase and sale	---6K	-500.00%-12K	--0	--0	---12K	--0	93.10%-2K	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	---6K	-500.00%-12K	--0	--0	---12K	--0	93.10%-2K	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	64.37%45.69M	5,947.35%27.54M	56.48%-205K	-51K	0	27.8M	-102.11%-471K	-471K	0	0
Net common stock issuance	----	--0	----	----	----	----	-99.95%11K	----	----	----
Net preferred stock issuance	65.62%50M	--30.19M	--0	--0	--0	--30.19M	--0	--0	--0	--0
Net other financing activities	-80.07%-4.31M	-449.59%-2.65M	---205K	---51K	--0	---2.39M	---482K	----	----	----
Cash from discontinued financing activities
Financing cash flow	64.37%45.69M	5,947.35%27.54M	56.48%-205K	---51K	--0	--27.8M	-102.11%-471K	---471K	--0	--0
Net cash flow
Beginning cash position	2,032.09%9.7M	-97.26%455K	104.64%14.35M	77.98%18.82M	78.65%24.33M	-97.26%455K	--16.58M	-61.08%7.01M	1,057,200.00%10.57M	9,165.31%13.62M
Current changes in cash	64.30%39.23M	157.34%9.25M	29.15%-4.64M	-25.54%-4.47M	-80.96%-5.51M	906.93%23.88M	-197.26%-16.12M	-357.75%-6.56M	-119.78%-3.56M	-1,986.99%-3.05M
End cash Position	101.09%48.93M	2,032.09%9.7M	2,032.09%9.7M	104.64%14.35M	77.98%18.82M	78.65%24.33M	-97.26%455K	-97.26%455K	-61.08%7.01M	1,057,200.00%10.57M
Free cash flow	-64.85%-6.46M	-16.88%-18.3M	27.04%-4.44M	-24.11%-4.42M	-80.96%-5.51M	-32.48%-3.92M	-170.07%-15.65M	-324.86%-6.08M	-2.56%-3.56M	-1,304.15%-3.05M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall